RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+15.11%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$796M
AUM Growth
+$796M
(+22%)
Cap. Flow
+$104M
Cap. Flow
% of AUM
13.04%
Top 10 Holdings %
Top 10 Hldgs %
37.64%
Holding
72
New
23
Increased
22
Reduced
9
Closed
16
Top Buys
| 1 |
Zimmer Biomet
ZBH
|
$34.3M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
$23.1M |
| 3 |
Incyte
INCY
|
$22.7M |
| 4 |
AGN
ALLERGAN INC
AGN
|
$21.9M |
| 5 |
Bristol-Myers Squibb
BMY
|
$21.3M |
Top Sells
| 1 |
Amgen
AMGN
|
$38.7M |
| 2 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
$28.8M |
| 3 |
STJ
St Jude Medical
STJ
|
$27.6M |
| 4 |
CTRX
CATAMARAN CORP COM STK (CDA)
CTRX
|
$23.3M |
| 5 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
$23.3M |
Sector Composition
| 1 | Healthcare | 86.89% |
| 2 | Consumer Staples | 1.21% |
| 3 | Technology | 0.56% |
| 4 | Communication Services | 0.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Gilead Sciences
GILD
$140B
| $48.6M | 6% | 647,287 +117,487 | +22% | +$8.83M |
|
|
CLVS
2
DELISTED
Clovis Oncology, Inc.
CLVS
| $34.5M | 4.26% | 572,270 +100,925 | +21% | +$6.08M |
|
|
3
Zimmer Biomet
ZBH
$21B
| $34.3M | 4.23% | +367,640 | New | +$34.3M |
|
|
CELG
4
DELISTED
Celgene Corp
CELG
| $30.9M | 3.82% | 183,018 +84,418 | +86% | +$14.3M |
|
5
AstraZeneca
AZN
$248B
| $30.3M | 3.74% | 511,120 +275,020 | +116% | +$16.3M |
|
|
AGN
6
DELISTED
Allergan plc
AGN
| $28.9M | 3.57% | 172,240 -99,260 | -37% | -$16.7M |
|
7
Puma Biotechnology
PBYI
$254M
| $23.9M | 2.95% | 230,673 -109,492 | -32% | -$11.3M |
|
|
8
Jazz Pharmaceuticals
JAZZ
$7.75B
| $23.1M | 2.85% | +182,561 | New | +$23.1M |
|
|
9
Incyte
INCY
$16.5B
| $22.7M | 2.81% | +448,998 | New | +$22.7M |
|
|
ARRY
10
DELISTED
Array Biopharma Inc
ARRY
| $22.3M | 2.76% | 4,460,688 +791,095 | +22% | +$3.96M |
|
|
AGN
11
DELISTED
ALLERGAN INC
AGN
| $22.2M | 2.74% | 199,727 +197,100 | +7,503% | +$21.9M |
|
12
Globus Medical
GMED
$8.27B
| $21.9M | 2.71% | 1,086,637 +350,537 | +48% | +$7.07M |
|
|
13
Bristol-Myers Squibb
BMY
$96B
| $21.3M | 2.63% | +400,870 | New | +$21.3M |
|
|
HTWR
14
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $20.9M | 2.57% | 222,023 +36,898 | +20% | +$3.47M |
|
|
KYTH
15
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $20.8M | 2.56% | 557,761 +329,543 | +144% | +$12.3M |
|
16
Amicus Therapeutics
FOLD
$2.34B
| $20.3M | 2.51% | 8,648,087 +6,174,300 | +250% | +$14.5M |
|
17
HCA Healthcare
HCA
$94.5B
| $20M | 2.47% | 419,100 +4,700 | +1% | +$224K |
|
18
Tenet Healthcare
THC
$16.3B
| $19.4M | 2.4% | 461,402 -129,598 | -22% | -$5.46M |
|
|
OXFD
19
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $18.3M | 2.26% | +946,457 | New | +$18.3M |
|
|
ICPT
20
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $18.2M | 2.24% | +265,949 | New | +$18.2M |
|
|
RCPT
21
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $18.1M | 2.24% | 625,133 +604,333 | +2,905% | +$17.5M |
|
|
NUVA
22
DELISTED
NuVasive, Inc.
NUVA
| $17.8M | 2.2% | 550,914 -142,478 | -21% | -$4.61M |
|
23
Universal Health Services
UHS
$11.6B
| $16.7M | 2.06% | +205,300 | New | +$16.7M |
|
24
Pfizer
PFE
$141B
| $16.4M | 2.03% | +536,000 | New | +$16.4M |
|
25
Accuray
ARAY
$157M
| $15.2M | 1.88% | 1,744,811 +671,012 | +62% | +$5.84M |
|